ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mylan launches DURART R 450
expressbpd
November 17, 2017Mylan has serious concerns about Teva’s ability to integrate and efficiently run a combined company, and deliver meaningful shareholder value, he said, adding “there is simply no track record for investors to find”. (Reuters)
Pharma Sources Insight January 2025
